Aortic & peripheral vascular diseaseMeta-analysis

Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis

Eur J Prev CardiolPublished

  • Pooled analysis of prospective cohort studies and updated meta-analysis
  • individual-level data from 3 cohorts
  • random-effects meta-analysis

Authors' conclusion

Collectively, the data reveal notable differences in associations by SFA sub-types

Study context

Population
Adults without prior vascular disease at baseline in EPIC-CVD, UK Biobank and INTERVAL
Participants
172,891 adults · 3 cohorts
Comparison
Per 1-SD higher circulating FA concentrations
Outcome
Cardiovascular disease (CVD), including incident CHD and stroke, and CVD mortality

Pooled result

As reported in the abstract

HR per 1-SD higher FA concentration
Even-chain SFA, coronary heart disease (CHD) (EPIC-CVD)
HR 1.24 (95% CI 1.18-1.32)
Even-chain SFA, stroke (EPIC-CVD)
HR 1.23 (1.10-1.38)
Odd-chain SFA, CHD (EPIC-CVD)
HR 0.82 (0.76-0.87)
Odd-chain SFA, stroke (EPIC-CVD)
HR 0.73 (0.67-0.78)
Longer-chain SFA, CHD (EPIC-CVD)
HR 0.95 (0.80-1.12)
Longer-chain SFA, stroke (EPIC-CVD)
HR 0.84 (0.72-0.99)
Total n-3 polyunsaturated FA (PUFA), incident CHD (combined)
HR 0.91 (0.85-0.97)
Docosahexaenoic acid (DHA), incident CHD (combined)
HR 0.91 (0.84-0.98)
Total n-6 PUFA, incident stroke (combined)
HR 0.94 (0.91-0.98)
Linoleic acid, incident stroke (combined)
HR 0.89 (0.83-0.95)

Further pooled results

Updated meta-analyses (37 fatty acids (FAs), 49 non-overlapping studies)

Broadly similar results; significant inverse associations of individual long-chain n-3 PUFAs and linoleic acid (LA) with both CHD and stroke
  • 7787 to 22 802 CHD cases; 6499 to 14 221 stroke cases

RCT evidence

Long-chain n-3 PUFA findings consistent with published randomized controlled trials (RCTs) on CHD despite insufficient evidence in monotherapy; unclear for other FAs

Original publication

Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis. Eur J Prev Cardiol. Published 4 October 2024. doi:10.1093/eurjpc/zwae315

Summarised from the published abstract; every number is checked against it